Early characterization and prediction of glioblastoma and brain metastasis treatment efficacy using medical imaging-based radiomics and artificial intelligence algorithms
Open Access
- 30 January 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1497195
Abstract
Among brain tumors, glioblastoma (GBM) is the most common and the most aggressive type, and brain metastases (BMs) occur in 20%–40% of cancer patients. Even with intensive treatment involving radiotherapy and surgery, which frequently leads to cognitive decline due to doses on healthy brain tissue, the median survival is 15 months for GBM and about 6 to 9 months for BM. Despite these treatments, GBM patients respond heterogeneously as do patients with BM. Following standard of care, some patients will respond and have an overall survival of more than 30 months and others will not respond and will die within a few months. Differentiating non-responders from responders as early as possible in order to tailor treatment in a personalized medicine fashion to optimize tumor control and preserve healthy brain tissue is the most pressing unmet therapeutic challenge. Innovative computer solutions recently emerged and could provide help to this challenge. This review will focus on 52 published research studies between 2013 and 2024 on (1) the early characterization of treatment efficacy with biomarker imaging and radiomic-based solutions, (2) predictive solutions with radiomic and artificial intelligence-based solutions, (3) interest in other biomarkers, and (4) the importance of the prediction of new treatment modalities’ efficacy.Keywords
All Related Versions
Funding Information
- Région Normandie
This publication has 61 references indexed in Scilit:
- Predicting survival in glioblastoma with multimodal neuroimaging and machine learningJournal of Neuro-Oncology, 2023
- A deep learning model for discriminating true progression from pseudoprogression in glioblastoma patientsJournal of Neuro-Oncology, 2022
- Predicting the outcome of radiotherapy in brain metastasis by integrating the clinical and MRI‐based deep learning featuresMedical Physics, 2022
- Radiomics for precision medicine in glioblastomaJournal of Neuro-Oncology, 2022
- Radiomics, machine learning, and artificial intelligence—what the neuroradiologist needs to knowNeuroradiology, 2021
- Applications of radiomics and machine learning for radiotherapy of malignant brain tumorsStrahlentherapie und Onkologie, 2020
- Radiomics Based on Multimodal MRI for the Differential Diagnosis of Benign and Malignant Breast LesionsJournal of Magnetic Resonance Imaging, 2020
- Diagnostic accuracy of magnetic resonance imaging techniques for treatment response evaluation in patients with high-grade glioma, a systematic review and meta-analysisEuropean Radiology, 2017
- Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain MetastasesJAMA, 2016
- Multimodal imaging based on MRI and PET reveals [18F]FLT PET as a specific and early indicator of treatment efficacy in a preclinical model of recurrent glioblastomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2015